Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Welcia Holdings (3141 JP)
Watchlist
170
Analysis
Consumer Staples
•
Japan
WELCIA HOLDINGS CO.,LTD. is a holding company established through a merger of Welcia Kanto and Takada Pharmacy. The Group mainly operates drug chain stores which sell medicines, health foods, cosmetics, nursery items and daily necessity goods.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Thematic (Sector/Industry)
•
12 Aug 2025 08:00
Japanese Big Retailers: Winners and Losers
An in-depth review of Japan retailers with sales of ¥250+ in 2025: ​FMCG retailers dominate with market concentration increasing, discounters...
Michael Causton
Follow
424 Views
Share
bullish
•
Tsuruha Holdings
•
06 Jan 2026 06:17
Tsuruha-Welcia Merger to Form Biggest Drugstore Alliance, +Aeon TOB
Today January 6, 2026 is the expiration of the TOB period initiated by Aeon (8267) for 50.9% of shares of Tsuruha (3391) up from 41%, with possible...
Jay Cameron
Follow
2.1k Views
Share
bearish
•
Hong Kong Exchanges and Clearing
•
19 Nov 2023 05:30
Index Rebalance & ETF Flow Recap: FRTIB, Japan, CSI300, CSI500, STAR50, WuXi XDC, Asahi
This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...
Brian Freitas
Follow
1.1k Views
Share
bullish
•
Welcia Holdings
•
23 Apr 2026 20:17
Primer: Welcia Holdings (3141 JP) - Apr 2026
Welcia Holdings is a leading Japanese drugstore chain, operating over 2,800 stores nationwide, with a business model centered on the...
αSK Primers
125 Views
Share
bullish
•
Thematic (Sector/Industry)
•
25 Aug 2026 08:00
M&A a Key Tool to Gain Market Share in Japanese Retailing
Japan’s top 81 companies control 48% of all retail sales as of FY2025, up 5.2 points in a single year. M&A was the main reason and the pace of...
Michael Causton
Follow
111 Views
Share
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x